Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer.
Ferrari N, Granata I, Capaia M, Piccirillo M, Guarracino MR, Venè R, Brizzolara A, Petretto A, Inglese E, Morini M, Astigiano S, Amaro AA, Boccardo F, Balbi C, Barboro P.
Ferrari N, et al. Among authors: vene r.
Cell Commun Signal. 2017 Dec 8;15(1):51. doi: 10.1186/s12964-017-0206-x.
Cell Commun Signal. 2017.
PMID: 29216878
Free PMC article.